BRIAN CALLAHAN: Open Payments
NPI 1932153301 · BOICEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 52 payments from 9 companies in 2025. Trend: 2023 $1,187 · 2024 $949 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $331 |
| ABBVIE INC. | 10 | $235 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $148 |
| PFIZER INC. | 10 | $143 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Inspire Medical Systems, Inc. | 1 | $41 |
| Novo Nordisk Inc | 2 | $34 |
| Lilly USA, LLC | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
Products named: FARXIGA, JARDIANCE, UBRELVY, PAXLOVID, AIRSUPRA, VRAYLAR, TRELEGY ELLIPTA, QULIPTA.
Industry payments across NY — which companies pay providers there.
